News

Filter

Current filters:

ResearchNeurological

1 to 9 of 503 results

Alzheimer’s Research UK launches £30m Drug Discovery Alliance

Alzheimer’s Research UK launches £30m Drug Discovery Alliance

16-02-2015

Dementia research charity Alzheimer’s Research UK has announced a £30 million ($46 million) Drug Discovery…

Aging-associated diseasesNeurologicalPharmaceuticalResearchUK

Voyager inks up to $845 million deal with Genzyme on novel CNS products

Voyager inks up to $845 million deal with Genzyme on novel CNS products

12-02-2015

US gene therapy start-up company Voyager Therapeutics has entered into a major strategic collaboration…

BiotechnologyGenzymeLicensingNeurologicalResearchSanofiUSAVoyager Therapeutics

Anavex confirms positive preclinical data for lead candidate ANAVEX 2-73 in epilepsy

Anavex confirms positive preclinical data for lead candidate ANAVEX 2-73 in epilepsy

10-02-2015

Neurological biopharma company Anavex Life Sciences has confirmed positive preclinical data for lead…

AnavexANAVEX 2-73NeurologicalPharmaceuticalResearchUSA

Could there be a Gleevec for brain cancer?

Could there be a Gleevec for brain cancer?

10-02-2015

The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid…

BiotechnologyGleevecNeurologicalNovartisResearch

UCB’s Phase III results for Neupro will back filing in China this year

UCB’s Phase III results for Neupro will back filing in China this year

05-02-2015

Belgian drugmaker UCB has announced positive top-line results from two Phase III studies of Neupro (rotigotine…

ChinaNeuproNeurologicalPharmaceuticalResearchUCB

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

27-01-2015

While current treatments for Alzheimer’s disease are only able to ease symptoms temporarily, tau-based…

AC ImmuneBiotechnologycrenezumabEli LillygantenerumabJohnson & JohnsonMarkets & MarketingNeurologicalResearchRochesolanezumabVaccines

Gedeon Richter and Actavis announce positive results from Phase III trial of cariprazine in schizophrenia

Gedeon Richter and Actavis announce positive results from Phase III trial of cariprazine in schizophrenia

20-01-2015

Hungary’s largest pharma company Gedeon Richter and Ireland-headquartered generics major Actavis have…

ActaviscariprazineGedeon RichterNeurologicalPharmaceuticalResearch

Addex Therapeutics teams up with Dystonia Medical Research Foundation on dipraglurant

Addex Therapeutics teams up with Dystonia Medical Research Foundation on dipraglurant

19-01-2015

Swiss pharma company Addex Therapeutics is to enter into a collaboration with the Dystonia Medical Research…

Addex PharmadipraglurantNeurologicalPharmaceuticalResearch

1 to 9 of 503 results

COMPANY SPOTLIGHT

Menarini

Back to top